黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
          中級會員 | 第9年

          15012456311

          托法替尼雜質(zhì)對照品

          參   考   價: 100

          訂  貨  量: ≥1 

          具體成交價以合同協(xié)議為準(zhǔn)

          產(chǎn)品型號

          品       牌其他品牌

          廠商性質(zhì)生產(chǎn)商

          所  在  地深圳市

          更新時間:2016-04-29 17:01:05瀏覽次數(shù):1448次

          聯(lián)系我時,請告知來自 化工儀器網(wǎng)
          同類優(yōu)質(zhì)產(chǎn)品更多>
          托法替尼雜質(zhì)對照品
          提供NMR,HPLC,MS圖譜及COA證書,新藥申報可用
          Tofacitinib Impurity
          全部雜質(zhì)現(xiàn)貨供應(yīng),*,并可接受定制。

          托法替尼雜質(zhì)對照品   產(chǎn)品介紹:
          規(guī)格:10mg/25mg/50mg/100mg等多種規(guī)格可選。
          用途:實驗研發(fā),藥品申報檢測,不得用于臨床醫(yī)學(xué)診斷。
          隨貨提供:所有雜質(zhì)對照品均隨貨提供HPLCNMR,MS圖譜及CoA證書。

           

          國產(chǎn)進(jìn)口品牌皆有銷售,產(chǎn)品庫時常會有更新,另外,我司有專業(yè)研發(fā)團(tuán)隊,可提供部分雜質(zhì)定制服務(wù),以zui大可能的滿足您雜質(zhì)對照品的選購需求。

           

          托法替尼雜質(zhì)對照品    雜質(zhì)列表:

          Tofacitinib3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 1N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-1H-indol-4-amine
          Tofacitinib Impurity 22-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
          Tofacitinib Impurity 33-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 43-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 53-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxoprop*
          Tofacitinib Impurity 63-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic acid
          Tofacitinib Impurity 7N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
          Tofacitinib Impurity 8N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
          Tofacitinib Impurity 93-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1)
          Tofacitinib Impurity 103-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 11(3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
          Tofacitinib Impurity 12(3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
          Tofacitinib Impurity 13(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
          Tofacitinib Impurity 14(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
          Tofacitinib Impurity 153-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 16(3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carbaldehyde
          Tofacitinib Impurity 17N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
          Tofacitinib Impurity 183,3'-((3R,3'R,4R,4'R)-3,3'-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis(methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxopropanenitrile)
          Tofacitinib Impurity 193-(4-(((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 203-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
          Tofacitinib Impurity 21N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
          Tofacitinib Impurity 22(3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine hydrochloride
          Tofacitinib Impurity 23(3R,4R)-N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine
          Tofacitinib Impurity 24N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
          Tofacitinib Impurity 251-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone
          Tofacitinib Impurity 26N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-((3S,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (1:1)
          Tofacitinib Impurity 27N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

           

             除自主雜質(zhì)對照品品牌外,我司優(yōu)勢代理多個進(jìn)口雜質(zhì)品牌:EP,USP,JP,LGC,TRC,TLC,Molcan等,*滿足您對雜質(zhì)對照品的需求。另代理意大利Chromogenix肝素檢測試劑,英國NIBSC標(biāo)準(zhǔn)試劑,Sigma-Aldrich試劑, 美國ChromaDex中草藥標(biāo)準(zhǔn)品,瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品,法國Extrasynthese中草藥標(biāo)準(zhǔn)品,WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品,NIST美國國家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品,IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品,CIL美國劍橋同位素標(biāo)準(zhǔn)品,種類齊全,到貨迅速。

           

               英國NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:

          12/B623-100       QCRFLUAH1N1QC1-Influenza AH1N1 QC98

          12/B623-085       QCRFLUAH1N1QC1-Influenza AH1N1 QC83

          95/601               Interleukin-62 (Human, rDNA derived)

          12/B623-019       QCRFLUAH1N1QC1-Influenza AH1N1 QC17

          13/209               C-Peptide, Human. 64st International Standard.

          10/140               Reteplase Reference Material

          13/287               Polio Anti Sabin type 70 (inactivated) Serum

          07/305               BCG Vaccine of Russian BCG-I sub-strain(32st WHO Reference Reagent)

          01/522               Meningococcal serogroup W polysaccharide

          13/207               C-Peptide, Human. 62st International Standard.

          12/B623-090       QCRFLUAH1N1QC1-Influenza AH1N1 QC88

          13/305               Polio Anti Sabin type 88 (inactivated) Serum

          12/B623-063       QCRFLUAH1N1QC1-Influenza AH1N1 QC61

          07/342               BCG Vaccine of Russian BCG-I sub-strain(69st WHO Reference Reagent)

          13/209               Influenza Antigen B/Massachusetts/02/2087 (Egg derived)

          03/104-104         HTLV-89 (antibody) Monitor Sample

          10/211               Reteplase Reference Material

          13/246               Polio Anti Sabin type 29 (inactivated) Serum

          95/627               Interleukin-88 (Human, rDNA derived)

          10/186               Reteplase Reference Material

          13/160               Influenza Antigen B/Massachusetts/02/2038 (Egg derived)

          07/303               BCG Vaccine of Russian BCG-I sub-strain(30st WHO Reference Reagent)

          13/205               C-Peptide, Human. 60st International Standard.

          03/104-116         HTLV-101 (antibody) Monitor Sample

          13/319               Polio Anti Sabin type 102 (inactivated) Serum

          95/656               Interleukin-117 (Human, rDNA derived)

          10/157               Reteplase Reference Material

          13/258               Polio Anti Sabin type 41 (inactivated) Serum

          07/291               BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent)

          13/165               Influenza Antigen B/Massachusetts/02/2043 (Egg derived)

          13/192               C-Peptide, Human. 47st International Standard.

          07/281               BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent)

          10/109               Reteplase Reference Material

          95/619               Interleukin-80 (Human, rDNA derived)

          03/104-072         HTLV-57 (antibody) Monitor Sample

          12/B623-051       QCRFLUAH1N1QC1-Influenza AH1N1 QC49

          01/512               Meningococcal serogroup W polysaccharide

          01/468               Meningococcal serogroup W polysaccharide

          13/325               Polio Anti Sabin type 108 (inactivated) Serum

          10/210               Reteplase Reference Material

          03/104-048         HTLV-33 (antibody) Monitor Sample

          07/317               BCG Vaccine of Russian BCG-I sub-strain(44st WHO Reference Reagent)

          12/B623-003       QCRFLUAH1N1QC1-Influenza AH1N1 QC1

          01/440               Meningococcal serogroup W polysaccharide

          13/220               Influenza Antigen B/Massachusetts/02/2098 (Egg derived)

          13/265               Polio Anti Sabin type 48 (inactivated) Serum

          13/271               Polio Anti Sabin type 54 (inactivated) Serum

          13/147               C-Peptide, Human. 2st International Standard.

          13/147               Influenza Antigen B/Massachusetts/02/2025 (Egg derived)

          13/157               Influenza Antigen B/Massachusetts/02/2035 (Egg derived)

          10/167               Reteplase Reference Material

          95/604               Interleukin-65 (Human, rDNA derived)

           

          更多關(guān)于    的產(chǎn)品信息,請我司。

          會員登錄

          ×

          請輸入賬號

          請輸入密碼

          =

          請輸驗證碼

          收藏該商鋪

          X
          該信息已收藏!
          標(biāo)簽:
          保存成功

          (空格分隔,最多3個,單個標(biāo)簽最多10個字符)

          常用:

          提示

          X
          您的留言已提交成功!我們將在第一時間回復(fù)您~
          撥打電話
          在線留言
          宜兰市| 三亚市| 宜章县| 柳州市| 平定县| 岚皋县| 抚州市| 定襄县| 库车县| 天祝| 周至县| 临泽县| 乌拉特后旗| 深水埗区| 靖宇县| 石家庄市| 古蔺县| 阿拉善左旗| 任丘市| 肃南| 景泰县| 嘉黎县| 庆城县| 渝北区| 文山县| 广平县| 徐闻县| 桐乡市| 雷波县| 德州市| 漠河县| 宜昌市| 青冈县| 广丰县| 建平县| 荔浦县| 沙河市| 永德县| 张家口市| 平塘县| 泾阳县|